Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice.
antiviral
dengue virus
host restriction
mouse model
vaccine
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
23 03 2023
23 03 2023
Historique:
received:
17
02
2023
revised:
19
03
2023
accepted:
20
03
2023
medline:
1
5
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
Dengue virus serotypes 1 to 4 (DENV1-4) place nearly half the global population at risk of infection and the licenced tetravalent dengue vaccine fails to protect individuals who have not previously been exposed to DENV. The development of intervention strategies had long been hampered by the lack of a suitable small animal model. DENV does not replicate in wild-type mice due to its inability to antagonise the mouse type I interferon (IFN) response. Mice deficient in type I IFN signalling (
Identifiants
pubmed: 37112795
pii: v15040814
doi: 10.3390/v15040814
pmc: PMC10142689
pii:
doi:
Substances chimiques
Interferon Type I
0
Antibodies, Blocking
0
Dengue Vaccines
0
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Immunol. 2007 May 1;178(9):5839-47
pubmed: 17442968
J Immunol. 2006 Mar 15;176(6):3315-9
pubmed: 16517698
J Immunol. 2006 Apr 15;176(8):4682-9
pubmed: 16585561
mBio. 2015 Sep 15;6(5):e01316-15
pubmed: 26374123
J Immunol. 2006 Feb 15;176(4):2074-8
pubmed: 16455962
PLoS Pathog. 2010 Feb 12;6(2):e1000790
pubmed: 20168989
J Virol. 2008 Apr;82(8):3939-51
pubmed: 18272578
Cell Host Microbe. 2010 Nov 18;8(5):410-21
pubmed: 21075352
Sci Transl Med. 2011 Dec 21;3(114):114ra128
pubmed: 22190239
PLoS Negl Trop Dis. 2017 Jan 9;11(1):e0005296
pubmed: 28068342
J Virol. 1999 Jan;73(1):783-6
pubmed: 9847388
N Engl J Med. 2015 Sep 24;373(13):1195-206
pubmed: 26214039
J Gen Virol. 2012 Oct;93(Pt 10):2152-2157
pubmed: 22815273
J Exp Med. 2005 Sep 5;202(5):637-50
pubmed: 16129706
J Interferon Cytokine Res. 2006 Nov;26(11):804-19
pubmed: 17115899
Front Immunol. 2019 Jun 21;10:1424
pubmed: 31293584
Cell Host Microbe. 2016 May 11;19(5):720-30
pubmed: 27066744
PLoS Pathog. 2012;8(10):e1002934
pubmed: 23055924
Vaccine. 2015 Mar 17;33(12):1474-82
pubmed: 25659270
J Immunol. 1988 Jun 15;140(12):4231-7
pubmed: 2453573
J Immunol. 2005 Apr 15;174(8):4465-9
pubmed: 15814665
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
J Exp Med. 2020 Sep 7;217(9):
pubmed: 32584412
PLoS Pathog. 2011 Dec;7(12):e1002407
pubmed: 22144897
J Immunol. 2007 Feb 15;178(4):2182-91
pubmed: 17277123
J Gen Virol. 2015 Oct;96(10):3035-3048
pubmed: 26296350
J Virol. 2014 Jul;88(13):7276-85
pubmed: 24741106
Curr Opin Virol. 2020 Aug;43:50-58
pubmed: 32950933
Science. 2010 May 7;328(5979):745-8
pubmed: 20448183
J Infect Dis. 2000 Jan;181(1):2-9
pubmed: 10608744
BMC Biol. 2020 Aug 27;18(1):106
pubmed: 32854687
Virology. 2021 Feb;554:28-36
pubmed: 33352463
Cell Host Microbe. 2018 May 9;23(5):672-685.e6
pubmed: 29746837
Eur J Immunol. 2006 Aug;36(8):2094-105
pubmed: 16810635
Science. 2017 Nov 17;358(6365):929-932
pubmed: 29097492
Clin Microbiol Rev. 2009 Oct;22(4):564-81
pubmed: 19822889
Vaccine. 2017 Nov 7;35(47):6355-6358
pubmed: 29029938
PLoS Negl Trop Dis. 2010 Apr 27;4(4):e672
pubmed: 20436920
J Virol. 2004 Mar;78(6):2701-10
pubmed: 14990690
Nature. 1977 Feb 24;265(5596):739-41
pubmed: 404559
Eur J Immunol. 2006 Aug;36(8):2046-60
pubmed: 16856207
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Science. 2006 Jan 13;311(5758):236-8
pubmed: 16410525
J Gen Virol. 2017 Oct;98(10):2507-2519
pubmed: 28949904
N Engl J Med. 2018 Jul 26;379(4):327-340
pubmed: 29897841
Nat Immunol. 2003 Oct;4(10):1009-15
pubmed: 14502286
J Virol. 2015 Jan 15;89(2):1254-66
pubmed: 25392217
Immunity. 2001 Apr;14(4):461-70
pubmed: 11336691
Cell Host Microbe. 2010 Feb 18;7(2):128-39
pubmed: 20153282